BRIEF-Seair announces default on senior debt
* Seair Inc - defaulted on terms of its senior debt senior debt and is currently in negotiations with its creditors to develop a restructuring plan
Oct 13 Biomarin Pharmaceutical Inc
* UK regulatory agency approves continued enrollment in Biomarin phase 1/2 study of BMN 270 in Hemophilia a
* Biomarin Pharmaceutical Inc - Biomarin intends to resume enrollment in phase i/2 study before end of 2016
* Biomarin Pharmaceutical Inc - Safety and efficacy data from these patients will inform phase 2B study planned to begin in second half of 2017 Source text for Eikon: Further company coverage:
* Sets regular quarterly dividend of $0.2425 per share Source text for Eikon: Further company coverage:
Feb 24 Citigroup Inc on Friday said that U.S. government and regulatory agencies are investigating the bank's hiring practices.